Overview
Not-for-profit medical group providing care, research, and education.
Founded
1864
Deals ยท 12mo
11
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
UltraSight | Sep 2026Participated | $24 MSeries B | |
Transcripta Bio | Jul 2026Participated | $24 MSeries B | |
SyntaxBio | Jun 2026Participated | $14 MSeries A | |
Techcyte | May 2026Participated | $15 MOther Equity | |
ViewsML | Apr 2026Participated | $5 MSeed | |
Sub-Q Bionics | Mar 2026Participated | $2 MSeed | |
WHOOP | Mar 2026Participated | $575 MSeries G | |
Vitestro | Mar 2026Participated | $70 MSeries B | |
OpenEvidence | Jan 2026Participated | $250 MSeries D | |
BrightInsight | Jan 2026Participated | $13 MOther Equity | |
Lin Health | Dec 2025Participated | $11 MSeries A | |
Mediview XR | Oct 2025Led | $24 MSeries A | |
UltraSight | Sep 2026Participated | $24 MSeries B | |
Transcripta Bio | Jul 2026Participated | $24 MSeries B | |
SyntaxBio | Jun 2026Participated | $14 MSeries A | |
Techcyte | May 2026Participated | $15 MOther Equity | |
ViewsML | Apr 2026Participated | $5 MSeed | |
Sub-Q Bionics | Mar 2026Participated | $2 MSeed | |
WHOOP | Mar 2026Participated | $575 MSeries G | |
Vitestro | Mar 2026Participated | $70 MSeries B | |
OpenEvidence | Jan 2026Participated | $250 MSeries D | |
BrightInsight | Jan 2026Participated | $13 MOther Equity | |
Lin Health | Dec 2025Participated | $11 MSeries A | |
Mediview XR | Oct 2025Led | $24 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 15 |
| Series A | 4 | 20 |
| Series B | 1 | 27 |
| Series C+ | 1 | 16 |
| Other Equity | 2 | 11 |
| Debt | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Mar '11 | 1 |
| Apr '11 | 0 |
| May '11 | 0 |
| Jun '11 | 1 |
| Jul '11 | 1 |
| Aug '11 | 0 |
| Sep '11 | 0 |
| Oct '11 | 0 |
| Nov '11 | 0 |
| Dec '11 | 0 |
| Jan '12 | 0 |
| Feb '12 | 0 |
| Mar '12 | 0 |
| Apr '12 | 0 |
| May '12 | 1 |
| Jun '12 | 0 |
| Jul '12 | 0 |
| Aug '12 | 0 |
| Sep '12 | 1 |
| Oct '12 | 0 |
| Nov '12 | 1 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 0 |
| Mar '13 | 1 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 0 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 2 |
| May '14 | 1 |
| Jun '14 | 2 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 1 |
| Jan '15 | 1 |
| Feb '15 | 1 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 0 |
| Jul '15 | 1 |
| Aug '15 | 1 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 0 |
| Dec '15 | 1 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 1 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 1 |
| Sep '16 | 1 |
| Oct '16 | 1 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 1 |
| Mar '17 | 1 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 3 |
| Jul '17 | 2 |
| Aug '17 | 1 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 1 |
| Apr '18 | 1 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 1 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 1 |
| Mar '19 | 0 |
| Apr '19 | 1 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 1 |
| Aug '19 | 0 |
| Sep '19 | 2 |
| Oct '19 | 1 |
| Nov '19 | 1 |
| Dec '19 | 1 |
| Jan '20 | 3 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 1 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 2 |
| Jun '21 | 2 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 2 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 1 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 1 |
| May '22 | 1 |
| Jun '22 | 1 |
| Jul '22 | 2 |
| Aug '22 | 2 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 1 |
| Apr '23 | 0 |
| May '23 | 3 |
| Jun '23 | 2 |
| Jul '23 | 0 |
| Aug '23 | 2 |
| Sep '23 | 0 |
| Oct '23 | 2 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 2 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 2 |
| May '24 | 0 |
| Jun '24 | 2 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 3 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 2 |
| Feb '26 | 0 |
| Mar '26 | 3 |
| Apr '26 | 1 |
| May '26 | 1 |
| Jun '26 | 1 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 95 |
| AI & Machine Learning | 18 |
| Enterprise Software | 13 |
| Data, Analytics & IT | 7 |
| AR/VR | 6 |
| Space & Frontier Tech | 6 |
| Networks, Cloud & Communication | 5 |
| Fintech | 5 |
| Consumer & Lifestyle | 4 |
| Hardware & Robotics | 3 |
| Crypto & Blockchain | 3 |
| Manufacturing | 3 |
| Cybersecurity & Privacy | 2 |
| Education & Workforce | 1 |
| Clean Energy & Sustainability | 1 |
| Real Estate & Construction | 1 |
| Media & Entertainment | 1 |
| Professional Services | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 15 |
| $5M-$10M | 13 |
| $10M-$25M | 30 |
| $25M-$50M | 25 |
| $50M-$100M | 8 |
| $100M-$250M | 7 |
| $250M-$500M | 1 |
| $500M-$1B | 1 |
| $1B+ | 0 |
Deals By Geography
Top 6 of 6 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 87 |
| Europe | 8 |
| Israel | 2 |
| Canada | 1 |
| China | 1 |
| 94133 | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Sequoia Capital | 7 |
| Alexandria Venture Investments | 6 |
| Canaan Partners | 6 |
| Cincinnati Children | 5 |
| Claremont Creek Ventures | 5 |
| Kleiner Perkins | 5 |
| Accuitive Medical Ventures | 4 |
| Allos Ventures | 4 |
| CincyTech | 4 |
| GE Ventures | 4 |
| Johnson & Johnson Innovation | 4 |
| Kaiser Permanente Ventures | 4 |
| 5AM Ventures | 3 |
| ARTIS Ventures | 3 |
| Eclipse Ventures | 3 |
| Flagship Pioneering | 3 |
| GE Healthcare | 3 |
| General Catalyst | 3 |
| JAZZ Venture Partners | 3 |
| Kaiser Permanente | 3 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 10 | 10% |
| Participating | 90 | 90% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 20% |
| Co-led | 8 | 80% |
Team
Chief Information Security Officer
Chief Resident
CEO, Mayo Clinic in Florida | Vice President, Mayo Clinic
President & CEO
CLO and Secretary
Cardiovascular Consultant
Chief Nursing Officer
Professor